tofacitinib
Showing 251 - 258 of 258
Healthy Trial in New Haven (Tasocitinib (CP-690,550) plus Rifampin)
Completed
- Healthy
- Tasocitinib (CP-690,550) plus Rifampin
-
New Haven, ConnecticutPfizer Investigational Site
Oct 21, 2010
Healthy Trial in Singapore (Tasocitinib 10 mg oral tablet, Tasocitinib 10 mg IV Infusion)
Completed
- Healthy
- Tasocitinib 10 mg oral tablet
- Tasocitinib 10 mg IV Infusion
-
Singapore, SingaporePfizer Investigational Site
Aug 6, 2010
Healthy Trial in Bruxelles (ethinyloestradiol (EE) and levonorgestrel (LN), CP-690,550 + ethinyloestradiol (EE) and
Completed
- Healthy
- ethinyloestradiol (EE) and levonorgestrel (LN), CP-690,550 + ethinyloestradiol (EE) and levonorgestrel (LN)
- CP-690,550 + ethinyloestradiol (EE) and levonorgestrel (LN), ethinyloestradiol (EE) and levonorgestrel (LN)
-
Bruxelles, BelgiumPfizer Investigational Site
Aug 5, 2010
Arthritis, Rheumatoid Trial in Woburn (CP 690,550 oral solutions)
Completed
- Arthritis, Rheumatoid
- CP 690,550 oral solutions
-
Woburn, MassachusettsPfizer Investigational Site
Jun 14, 2010
Hepatic Insufficiency Trial in South Miami (CP-690,550)
Completed
- Hepatic Insufficiency
-
South Miami, FloridaPfizer Investigational Site
Feb 10, 2010
Healthy Volunteer Trial in New Haven (midazolam; CP-690,550 + midazolam, CP-690,550 + midazolam; midazolam)
Completed
- Healthy Volunteer
- midazolam; CP-690,550 + midazolam
- CP-690,550 + midazolam; midazolam
-
New Haven, ConnecticutPfizer Investigational Site
Aug 12, 2009
Healthy Volunteers Trial in Singapore (CP- 690,550 and Tacrolimus, CP- 690,550 and Cyclosporine)
Completed
- Healthy Volunteers
- CP- 690,550 and Tacrolimus
- CP- 690,550 and Cyclosporine
-
Singapore, SingaporePfizer Investigational Site
Aug 12, 2009